Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century
Authors:
- 12 February 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (7) , 1408-1411
Abstract
Acute lymphoblastic leukemia (ALL) is an uncommon but highly fatal disease in adults. We used period analysis to data from the Surveillance, Epidemiology, and End Results (SEER) database to disclose changes in outcomes for patients diagnosed with ALL in the United States in the 2 decades between 1980–1984 and 2000–2004. Major improvement in survival was observed for patients less than 60 years of age. Improvement in survival was greater for women than for men, but was significant for both genders. The greatest improvement was seen in patients aged 15 to 19, in whom 5-year relative survival improved from 41.0% to 61.1%, and 10-year survival improved from 33.0% to 60.4%. Lesser but significant improvements were seen for age groups 20–29, 30–44, and 45–59. Survival for patients aged 60 and over remained essentially unchanged at levels around or below 10%, respectively. Survival has improved for patients with ALL over the time period studied, but treatment of older patients remains a difficult issue.Keywords
This publication has 20 references indexed in Scilit:
- Trends in 5- and 10-year Survival After Diagnosis with Childhood Hematologic Malignancies in the United States, 1990–2004JNCI: Journal of the National Cancer Institute, 2008
- Progress in the treatment of adults with acute lymphoblastic leukemiaCurrent Opinion in Hematology, 2008
- Up-to-date and Precise Estimates of Cancer Patient Survival: Model-based Period AnalysisAmerican Journal of Epidemiology, 2006
- Management of Acute Lymphoblastic Leukemia in Older PatientsSeminars in Hematology, 2006
- Treatment of Adult Acute Lymphoblastic LeukemiaHematology-American Society Hematology Education Program, 2006
- Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993Blood, 2005
- Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug AdministrationJournal of Clinical Oncology, 2004
- Period analysis for ‘up-to-date’ cancer survival dataEuropean Journal of Cancer, 2004
- Acute lymphoblastic leukemia in the elderly: The Edouard Herriot hospital experienceAmerican Journal of Hematology, 2001
- Acute Lymphoblastic Leukaemia in the ElderlyLeukemia & Lymphoma, 1994